Futurism Logo
Futurism Logo
    • Anthropic
    • Ethics
    • Facial recognition
    • Google
    • Machine Learning
    • Meta
    • OpenAI
    • xAI
    • Art
    • Blockchain
    • Cybersecurity
    • Education
    • FCC
    • Finance
    • Food
    • Privacy
    • The Industrialists
    • Virtual Reality
    • Brain
    • Developments
    • Genetics
    • Medical
    • Prosthetics and Devices
    • Sleep
    • Studies
    • Computing
    • Robotics
    • Agriculture
    • Biology
    • Chemistry
    • Energy
    • Environment
    • Evolution
    • Future Materials
    • Military
    • Physics
    • Astronomy
    • Astrophysics
    • Blue Origin
    • Boeing
    • ESA
    • NASA
    • Off-World
    • Space Force
    • SpaceX
    • Electric Vehicles
    • Mass Transit
    • Self-Driving Vehicles
    • Tesla
  • Latest
  • Newsletter
  • IG
  • BS
  • FB

eli lilly

Latest in eli lilly

Eli Lilly announced clinical trial results this week for a daily pill to treat obesity and diabetes. Its name is absolutely terrible.
Developments

Eli Lilly’s New Weight Loss Drug May Have the Worst Name in Pharmaceutical History

By Victor Tangermann

Shares of Novo Nordisk, the Danish pharmaceutical company behind weight-loss drugs Ozempic and Wegovy, plummeted this week.
Developments

Novo Nordisk Is Getting Absolutely Destroyed

By Victor Tangermann

A new study has found that Mounjaro may not only be good at treating diabetes, but could actually help prevent the disease.
RX and Medicine

Mounjaro Appears to Be Extremely Effective at Preventing Diabetes

By Noor Al-Sibai

Eli Lilly, the maker of the popular weight loss drug Zepbound, revealed a "shocking first miss" during its most recent quarterly sales.
Developments

Eli Lilly Has a Major Problem With Its Weight Loss Drugs Zepbound and Mounjaro

By Victor Tangermann

The makers of Zepbound are offering a massive price cut — if you're willing to purchase and dose your syringes out yourself. 
RX and Medicine

Eli Lilly Offering Way Cheaper Zepbound, If You’re Willing to Buy Your Own Syringes

By Noor Al-Sibai

New findings from a long-term study found that Zepbound and Mounjaro almost completely eliminates the risk of developing diabetes.
RX and Medicine

Taking Mounjaro Reduces Risk of Developing Diabetes by 94 Percent in Three-Year Trial

By Noor Al-Sibai

Eli Lilly, the maker of Zepbound, is hoping that new studies into off-label treatments will help get the drugs covered by insurance.
RX and Medicine

Drug Companies Have a Sneaky Idea to Get Insurance to Pay for Drugs Like Zepbound

By Noor Al-Sibai

Eli Lilly, the pharma firm behind Zepbound and Mounjaro is, ironically, calling people out for using the drugs to lose weight. 
RX and Medicine

Eli Lilly Blasts Use of Mounjaro and Zepbound for “Cosmetic Weight Loss”

By Noor Al-Sibai

Google's parent company, Alphabet, has poached Eli Lilly's chief financial officer and tapped her to be its own.
Future Society

Google Hires Weight Loss Drug Exec With Zero Tech Experience as New CFO

By Noor Al-Sibai

  • Newsletter
  • About Us
  • Editorial Standards
  • Contacts
  • Privacy Policy
  • Terms & Conditions
  • DMCA Policy
  • Sitemap

FOLLOW US

  • IG
  • BS
  • FB

DISCLAIMER(S)

Disclaimer(s)

Articles may contain affiliate links which enable us to share in the revenue of any purchases made. Registration on or use of this site constitutes acceptance of our Terms of Service.

© 2025 Recurrent. All rights reserved.

Do Not Sell or Share My Personal Information.

  • Advanced Transport

  • Artificial Intelligence

  • Future Society

  • Health & Medicine

  • Robots and Machines

  • Science & Energy

  • Space